Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125654211 | 12565421 | 1 | I | 20160617 | 20160718 | 20160718 | EXP | ES-ACTAVIS-2016-15664 | ACTAVIS | MART?N AJM, ALFONSO PG, RUP?REZ AB, JIM?NEZ MM. NAB-PACLITAXEL PLUS GEMCITABINE AS FIRST-LINE PALLIATIVE CHEMOTHERAPY IN A PATIENT WITH METASTATIC PANCREATIC CANCER WITH EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS OF 2. ONCOL LETT. 2016;12(1):727-730. | 68.00 | YR | F | Y | 46.00000 | KG | 20160718 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125654211 | 12565421 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | DAYS 1, 8 AND 15; EVERY 28 DAYS | UNCONFIRMED | 79160 | 400 | MG/M**2 | UNK | ||||||
| 125654211 | 12565421 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | DAYS 1, 8 AND 15;EVERY 28 DAYS( NAB-PACLITAXEL) | 0 | 50 | MG/M**2 | ||||||||
| 125654211 | 12565421 | 3 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 125654211 | 12565421 | 4 | C | OXYCODONE | OXYCODONE | 1 | Oral | 40 MG, UNK | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125654211 | 12565421 | 1 | Pancreatic carcinoma metastatic |
| 125654211 | 12565421 | 2 | Pancreatic carcinoma metastatic |
| 125654211 | 12565421 | 3 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125654211 | 12565421 | DE |
| 125654211 | 12565421 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125654211 | 12565421 | Anaemia | |
| 125654211 | 12565421 | Asthenia | |
| 125654211 | 12565421 | Cholangitis acute | |
| 125654211 | 12565421 | Diarrhoea | |
| 125654211 | 12565421 | Hepatotoxicity | |
| 125654211 | 12565421 | Lymphopenia | |
| 125654211 | 12565421 | Oedema peripheral | |
| 125654211 | 12565421 | Pyrexia | |
| 125654211 | 12565421 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125654211 | 12565421 | 1 | 201311 | 0 | ||
| 125654211 | 12565421 | 2 | 201311 | 0 |